by Eric Christianson | Oct 4, 2026 | Respiratory Medication and Disease State Clinical Pearls
A patient who keeps having asthma exacerbations can be frustrating to manage. It is easy to assume that the patient simply needs a stronger inhaler or additional medications. But before escalating therapy, it is important to figure out why the patient is not getting...
by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | May 21, 2025 | Infectious Disease and Oncology Case Studies
Nitrofurantoin is often used in patients for UTI prophylaxis. One potential concern with nitrofurantoin use is pulmonary toxicity. This can often be overlooked in patients as a potential cause of respiratory problems. Here’s a case scenario where nitrofurantoin...
by Eric Christianson | Jan 21, 2024 | Respiratory Medication and Disease State Clinical Pearls
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My...
by Eric Christianson | Mar 27, 2022 | Medication and Disease State Clinical Pearls For Pharmacists
COPD is a challenging disease that ultimately leads to a progressive reduction in lung function. Our mainstays of therapy are the bronchodilators like long-acting anticholinergic and long-acting beta-agonists. Roflumilast (podcast) is a unique medication for COPD in...
